Opus Genetics, Inc. (IRD)
4.605
+0.16
(+3.48%)
USD |
NASDAQ |
Sep 03, 16:00
4.65
+0.04
(+0.98%)
After-Hours: 18:24
Opus Genetics Shareholders Equity (Quarterly) : -12.99M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.99M |
| March 31, 2026 | -45.84M |
| December 31, 2025 | 15.35M |
| September 30, 2025 | 5.967M |
| June 30, 2025 | 17.47M |
| March 31, 2025 | 5.073M |
| December 31, 2024 | 6.724M |
| September 30, 2024 | 34.30M |
| June 30, 2024 | 40.64M |
| March 31, 2024 | 46.06M |
| December 31, 2023 | 49.91M |
| September 30, 2023 | 50.28M |
| June 30, 2023 | 37.70M |
| March 31, 2023 | 41.25M |
| December 31, 2022 | 46.24M |
| September 30, 2022 | 11.88M |
| June 30, 2022 | 14.60M |
| March 31, 2022 | 17.27M |
| December 31, 2021 | 22.22M |
| September 30, 2021 | 20.57M |
| June 30, 2021 | 22.55M |
| March 31, 2021 | 9.816M |
| December 31, 2020 | |
| September 30, 2020 | 5.714M |
| June 30, 2020 | 7.003M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.445M |
| December 31, 2019 | 9.958M |
| September 30, 2019 | 11.76M |
| June 30, 2019 | 13.62M |
| March 31, 2019 | 15.94M |
| December 31, 2018 | 10.56M |
| September 30, 2018 | 6.412M |
| June 30, 2018 | 11.42M |
| March 31, 2018 | 14.97M |
| December 31, 2017 | 16.77M |
| September 30, 2017 | 15.12M |
| June 30, 2017 | 15.90M |
| March 31, 2017 | 1.160M |
| December 31, 2016 | 17.06M |
| September 30, 2016 | 17.24M |
| June 30, 2016 | 15.81M |
| March 31, 2016 | 17.21M |
| December 31, 2015 | 18.78M |
| September 30, 2015 | 17.71M |
| June 30, 2015 | 21.43M |
| March 31, 2015 | 23.38M |
| December 31, 2014 | 26.58M |
| September 30, 2014 | 28.60M |
| June 30, 2014 | 30.31M |
| March 31, 2014 | 28.03M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 323.86M |
| Praxis Precision Medicines, Inc. | 1.341B |
| Faeth Therapeutics, Inc. | 179.72M |
| Jade Biosciences, Inc. | 439.92M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 92.97M |
| Total Liabilities (Quarterly) | 105.95M |
| Debt to Equity Ratio | -2.788 |
| Current Ratio | 12.19 |
| Net Debt Paydown Yield | -1.02% |